Literature DB >> 1733559

Suitability of cisplatin solutions for 14-day continuous infusion by ambulatory pump.

M Hrubisko1, A T Mc Gown, J A Prendiville, J A Radford, N Thatcher, B W Fox.   

Abstract

The stability of cisplatin (DDP) solutions (1 and 1.6 mg/ml in saline-mannitol) in plastic infusion bags was studied for up to 14 days at 25 degrees C, 37 degrees C and 60 degrees C. Small changes in the solution were observed, but no evidence of any decomposition product was seen. Some precipitation of DDP was seen in the 1.6-mg/ml solution at the lower temperatures. Fluid loss from the bags was significant at the higher temperatures.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1733559     DOI: 10.1007/bf00686261

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  7 in total

1.  Clinical and pharmacological studies with cis-diamminedichloroplatinum (II).

Authors:  R C DeConti; B R Toftness; R C Lange; W A Creasey
Journal:  Cancer Res       Date:  1973-06       Impact factor: 12.701

2.  Cell kinetics and growth of squamous cell carcinomas in man.

Authors:  F Bresciani; R Paoluzi; M Benassi; C Nervi; C Casale; E Ziparo
Journal:  Cancer Res       Date:  1974-09       Impact factor: 12.701

Review 3.  The cell cycle.

Authors:  R Baserga
Journal:  N Engl J Med       Date:  1981-02-19       Impact factor: 91.245

4.  Constant infusion schedule for adriamycin: a phase I-II clinical trial of a 30-day schedule by ambulatory pump delivery system.

Authors:  J Lokich; A Bothe; T Zipoli; R Green; H Sonneborn; S Paul; D Philips
Journal:  J Clin Oncol       Date:  1983-01       Impact factor: 44.544

Review 5.  Continuous infusion chemotherapy: a critical review.

Authors:  N J Vogelzang
Journal:  J Clin Oncol       Date:  1984-11       Impact factor: 44.544

Review 6.  Clinical pharmacology and pharmacokinetics of cis-platinum and analogs.

Authors:  P Ribaud; J Gouveia; M Bonnay; G Mathe
Journal:  Cancer Treat Rep       Date:  1981

7.  Adriamycin therapy by continuous intravenous infusion in patients with metastatic breast cancer.

Authors:  S S Legha; R S Benjamin; B Mackay; H Y Yap; S Wallace; M Ewer; G R Blumenschein; E J Freireich
Journal:  Cancer       Date:  1982-05-01       Impact factor: 6.860

  7 in total
  2 in total

1.  Evaluation of Cisplatin Efficacy on HepG2 and E. coli Cells under Acidic Conditions

Authors:  Faezeh Babaei; Hasan Ebrahimi Shahmabadi; Mohammad Reza Rajabi; Hamed Haddad Kashani; Fatemeh Izadpanah
Journal:  Asian Pac J Cancer Prev       Date:  2019-03-26

2.  The physical and chemical stability of cisplatin (Teva) in concentrate and diluted in sodium chloride 0.9%.

Authors:  Agnieszka Karbownik; Edyta Szałek; Hanna Urjasz; Aleksandra Głęboka; Emilia Mierzwa; Edmund Grześkowiak
Journal:  Contemp Oncol (Pozn)       Date:  2012-11-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.